NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Esco Lifesciences Group

Esco Lifesciences Group

Private
SingaporeHealthcare & Life Scienceshttps://www.escolifesciences.com/

Last Round

Series A

May 26, 2021

Est. Valuation

$844M

Total Funding Raised

$200M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Esco Lifesciences Group is a life sciences company that manufactures laboratory equipment, bioprocessing tools, and IVF medical devices for the global healthcare and research industries.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

laboratory equipmentbiopharmaceutical equipmentIVF equipmentbiological safety cabinetslab gearCO2 incubatorsbioprocessing systemscontrolled environmentlab automationaseptic processingultra-low temperature freezerscontract research development and manufacturing organizationCRDMOinstallation qualification and operational qualificationIQ/OQfertility techlab maintenance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Esco Lifesciences Group Comparables

Compare Esco Lifesciences Group with similar companies based on industry and business-model similarity.

Esco Lifesciences Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Haier Biomedical
82%
Eppendorf SE
79%
PHC Holdings Corporation
79%

Esco Lifesciences Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 26, 2021

Key People

Founding team and executive leadership

Lim Yae-Foong

Co-Founder, COO, & Executive Director

Founding Team

XiangQian XQ Lin

Chairman And CEO

Executive Team

Esco Lifesciences Group Investors

Notable investors and investment history

Esco Lifesciences Group investors
InvestorRounds
EDBISeries A
GIC Private LimitedSeries A
China Investment CorporationSeries A
Novo HoldingsSeries A
K3 VenturesSeries A
Vivo CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Will participate in INTERPHEX 2026 in New York City.

  • Mar 19, 2026

    Will participate in the ISPE Rocky Mountain Chapter 2026 event.

Esco Lifesciences Group Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Esco Lifesciences Group Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Esco Lifesciences Group's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range1,306
Year Founded1978
Last FundingMay 26, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.